Symbionix
Symbionix is a young team of gifted professionals in robotics, biotechnology, medicine, and marketing. We have been developing various exoskeletons as innovative products for rehabilitation medicine and industries. Symbionix has been engaged in the development of exoskeletons with various functional capabilities. The development efforts are focused on creation of hi-tech exoskeletons for rehabilitation of physically challenged people. Our company employs outstanding programming and cybernetics professionals, engineers and medical specialists. We do believe our products can enhance the quality of people’s living, give them new opportunities and open up new horizons. Our project makes it possible to set up an affordable market for people who need exoskeletons in their living. The Companion model has been unique primarily due to its specifications that are unrivalled on the global scale.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Symbionix strives to make fully functional prosthetic limbs universally accessible, giving amputees the chance to live normal lives. What sets us apart from our competitors is the sheer size and brute brilliance of its team. Symbionix leverages its student brainpower to engineer and build prosthetics that utilize some of today's premier technology. This innovation comes at no cost to the company, as the students are eager to learn and to gain experience. They expect very little in return. In fact, we pay no salaries, have no equity to give away, and yet still have the guidance of various Ph.D. candidates, professors, and business professionals.
As of now, we are focused on developing the Companion exoskeleton, a technologically sophisticated innovative device to assist people with spinal cord injuries abandon the armchair and walk. The exoskeleton is sought both by people with disabilities, and by the health centres committed to patient rehabilitation.
High price, along with imperfection of models that manifest a bunch of technical flaws now make the principal obstacle for exoskeleton sales in the Russian market. However, the higher need for similar devices has been expanding the relevant market, so increasingly more companies invest in similar projects, seeking to occupy their niches in the industry.
Over the two years of company existence, we have achieved substantial progress, but this could have been more efficient if we had reliable partners by our side.